Amersham Biosciences and GeneBio expand image analysis software alliance
US-based Amersham Biosciences and Geneva Bioinformatics (GeneBio), of Switzerland, have signed an exclusive agreement to provide researchers with the next generation of 2-D gel image analysis tools for proteomics research.
US-based Amersham Biosciences and Geneva Bioinformatics (GeneBio), of Switzerland, have signed an exclusive agreement to provide researchers with the next generation of 2-D gel image analysis tools for proteomics research.
This agreement expands the strategic alliance between the two companies signed in January 2003 to develop and distribute novel proteomics analysis software, databases and training tools.
The collaboration will entail the complete integration of the Melanie 2-D Gel Analysis Software, developed by the Swiss Institute of Bioinformatics (SIB), into the ImageMaster image analysis software platform from Amersham Biosciences. The new version of ImageMaster, incorporating Melanie, will help to address the current critical bottlenecks of image analysis in proteomics research by enhancing the speed and accuracy of the software and generating statistically accurate and pertinent results.
Under the agreement, future imaging software will be collaboratively developed utilising the strengths of Amersham Biosciences, GeneBio, the SIB and the Melanie backbone. 'This partnership demonstrates both companies' commitment to the field of 2-D image analysis and will enable Amersham Biosciences to build on the expertise GeneBio and the SIB have in the proteomics application area, and especially in proteomics analysis software and databases,' said Alan Livingston, marketing director of proteomics at Amersham Biosciences. 'The new version of ImageMaster will enable proteomics researchers to generate high quality biological data quickly and reliably.'